Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025 46.1% Revenue growth, 20253 Where the money goes Where each dollar of revenue went, fiscal 2025 Selling, general and admin Other costs
Selling, general and admin 11¢ $443.4M Other costs 89¢ $3.5B Income tax 0¢ $20.0K Out of $3.9B in revenue.3
Where each dollar of operating cash went, fiscal 2025 Capital spending Kept or used elsewhere
Capital spending 19¢ $26.8M Kept or used elsewhere 81¢ $113.1M Out of $139.9M of cash from operations.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 3 $3.9B in 2025+424% since 2019 0 $1.0B $2.0B $3.0B $4.0B 2019: $754.0M $754.0M 2019 2020: $955.4M $955.4M 2020 +27% 2021: $1.2B $1.2B 2021 +22% 2022: $1.4B $1.4B 2022 +23% 2023: $1.8B $1.8B 2023 +26% 2024: $2.7B $2.7B 2024 +50% 2025: $3.9B $3.9B 2025 +46% Operating income4 5 6 7 3 $14.8M in 2025-$200.0M -$150.0M -$100.0M -$50.0M 0 $50.0M 2019: -$29.5M -$29.5M 2019 2020: -$5.3M -$5.3M 2020 −82% 2021: -$178.1M -$178.1M 2021 +3283% 2022: -$128.6M -$128.6M 2022 −28% 2023: -$127.8M -$127.8M 2023 −1% 2024: -$101.6M -$101.6M 2024 −21% 2025: $14.8M $14.8M 2025 Net income4 5 6 7 3 -$724.0K in 2025−98% since 2019 -$200.0M -$150.0M -$100.0M -$50.0M 0 2019: -$44.7M -$44.7M 2019 2020: -$22.9M -$22.9M 2020 −49% 2021: -$195.3M -$195.3M 2021 +752% 2022: -$149.5M -$149.5M 2022 −23% 2023: -$148.0M -$148.0M 2023 −1% 2024: -$128.0M -$128.0M 2024 −13% 2025: -$724.0K -$724.0K 2025 −99% Revenue8 9 $1.3B in Q2 FY2026+8% since Q1 FY2026 0 $500.0M $1.0B $1.5B Q1 FY2026: $1.2B $1.2B Q1 FY2026 Q2 FY2026: $1.3B $1.3B Q2 FY2026 +8% Operating income8 9 $42.1M in Q2 FY2026+172% since Q1 FY2026 0 $20.0M $40.0M $60.0M Q1 FY2026: $15.5M $15.5M Q1 FY2026 Q2 FY2026: $42.1M $42.1M Q2 FY2026 +172% Net income8 9 $36.6M in Q2 FY2026+220% since Q1 FY2026 0 $10.0M $20.0M $30.0M $40.0M Q1 FY2026: $11.4M $11.4M Q1 FY2026 Q2 FY2026: $36.6M $36.6M Q2 FY2026 +220% Fiscal year 2019 2020 2021 2022 2023 2024 2025 Revenue $754.0M4 $955.4M5 $1.2B6 $1.4B6 $1.8B6 $2.7B3 $3.9B3 Selling, general and admin $110.1M4 $156.4M5 $291.0M6 $295.6M7 $307.4M3 $371.4M3 $443.4M3 Operating income -$29.5M4 -$5.3M5 -$178.1M6 -$128.6M7 -$127.8M3 -$101.6M3 $14.8M3 Interest $14.9M4 $16.9M5 $17.4M6 $18.3M6 $21.2M6 Income tax $04 $05 $06 $339.0K7 -$22.0K3 $21.0K3 $20.0K3 Net income -$44.7M4 -$22.9M5 -$195.3M6 -$149.5M7 -$148.0M3 -$128.0M3 -$724.0K3 Earnings per share -$0.155 -$1.146 -$0.837 -$0.793 -$0.673 $0.003 Earnings per share (diluted) -$0.155 -$1.146 -$0.837 -$0.793 -$0.673 $0.003
Total assets4 5 6 7 3 $1.1B in 2025+215% since 2020 0 $500.0M $1.0B $1.5B 2020: $338.5M $338.5M 2020 2021: $630.9M $630.9M 2021 +86% 2022: $633.9M $633.9M 2022 +0% 2023: $591.9M $591.9M 2023 −7% 2024: $782.1M $782.1M 2024 +32% 2025: $1.1B $1.1B 2025 +36% Total liabilities4 5 6 7 3 $886.5M in 2025+188% since 2020 0 $250.0M $500.0M $750.0M $1.0B 2020: $307.9M $307.9M 2020 2021: $324.8M $324.8M 2021 +6% 2022: $394.6M $394.6M 2022 +21% 2023: $433.8M $433.8M 2023 +10% 2024: $681.1M $681.1M 2024 +57% 2025: $886.5M $886.5M 2025 +30% Shareholders’ equity5 4 6 7 3 $179.3M in 2025-$100.0M 0 $100.0M $200.0M $300.0M $400.0M 2019: -$78.7M -$78.7M 2019 2020: $30.6M $30.6M 2020 2021: $306.0M $306.0M 2021 +900% 2022: $238.1M $238.1M 2022 −22% 2023: $156.9M $156.9M 2023 −34% 2024: $99.9M $99.9M 2024 −36% 2025: $179.3M $179.3M 2025 +80% Cash4 5 6 7 3 $575.8M in 2025+566% since 2019 0 $200.0M $400.0M $600.0M 2019: $86.5M $86.5M 2019 2020: $207.3M $207.3M 2020 +140% 2021: $466.6M $466.6M 2021 +125% 2022: $409.5M $409.5M 2022 −12% 2023: $202.9M $202.9M 2023 −50% 2024: $432.9M $432.9M 2024 +113% 2025: $575.8M $575.8M 2025 +33% Long-term debt4 5 6 7 3 $323.2M in 2025+124% since 2020 0 $100.0M $200.0M $300.0M $400.0M 2020: $144.2M $144.2M 2020 2021: $150.6M $150.6M 2021 +4% 2022: $160.9M $160.9M 2022 +7% 2023: $161.8M $161.8M 2023 +1% 2024: $321.4M $321.4M 2024 +99% 2025: $323.2M $323.2M 2025 +1% Total assets8 9 $1.3B in Q2 FY2026+20% since Q1 FY2025 0 $500.0M $1.0B $1.5B Q1 FY2025: $1.1B $1.1B Q1 FY2025 Q2 FY2025: $1.1B $1.1B Q2 FY2025 +0% Q1 FY2026: $1.3B $1.3B Q1 FY2026 +18% Q2 FY2026: $1.3B $1.3B Q2 FY2026 +1% Total liabilities8 9 $1.0B in Q2 FY2026+14% since Q1 FY2025 0 $500.0M $1.0B $1.5B Q1 FY2025: $886.5M $886.5M Q1 FY2025 Q2 FY2025: $886.5M $886.5M Q2 FY2025 +0% Q1 FY2026: $1.1B $1.1B Q1 FY2026 +19% Q2 FY2026: $1.0B $1.0B Q2 FY2026 −4% Shareholders’ equity8 9 $265.1M in Q2 FY2026+48% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $179.3M $179.3M Q1 FY2025 Q2 FY2025: $179.3M $179.3M Q2 FY2025 +0% Q1 FY2026: $206.9M $206.9M Q1 FY2026 +15% Q2 FY2026: $206.9M $206.9M Q2 FY2026 +0% Q2 FY2026: $265.1M $265.1M Q2 FY2026 +28% Cash8 9 $693.5M in Q2 FY2026+20% since Q1 FY2025 0 $200.0M $400.0M $600.0M $800.0M Q1 FY2025: $575.8M $575.8M Q1 FY2025 Q2 FY2025: $575.8M $575.8M Q2 FY2025 +0% Q1 FY2026: $705.6M $705.6M Q1 FY2026 +23% Q2 FY2026: $693.5M $693.5M Q2 FY2026 −2% Long-term debt8 9 $324.1M in Q2 FY2026+0% since Q1 FY2025 0 $100.0M $200.0M $300.0M $400.0M Q1 FY2025: $323.2M $323.2M Q1 FY2025 Q2 FY2025: $323.2M $323.2M Q2 FY2025 +0% Q1 FY2026: $323.6M $323.6M Q1 FY2026 +0% Q2 FY2026: $324.1M $324.1M Q2 FY2026 +0% Fiscal year 2019 2020 2021 2022 2023 2024 2025 Cash $86.5M4 $207.3M5 $466.6M6 $409.5M7 $202.9M3 $432.9M3 $575.8M3 Current assets $264.7M4 $552.9M5 $544.5M6 $483.5M7 $661.6M3 $951.6M3 Total assets $338.5M4 $630.9M5 $633.9M6 $591.9M7 $782.1M3 $1.1B3 Current liabilities $153.5M4 $167.2M5 $230.0M6 $263.0M7 $351.8M3 $556.9M3 Long-term debt $144.2M4 $150.6M5 $160.9M6 $161.8M7 $321.4M3 $323.2M3 Total liabilities $307.9M4 $324.8M5 $394.6M6 $433.8M7 $681.1M3 $886.5M3 Shareholders’ equity -$78.7M5 $30.6M4 $306.0M5 $238.1M6 $156.9M7 $99.9M3 $179.3M3 Shares outstanding 164.1M shares4 187.2M shares5 187.3M shares6 189.0M shares7 191.8M shares3 204.2M shares3
Cash from operations4 5 6 7 3 $139.9M in 2025+1420% since 2019 -$100.0M 0 $100.0M $200.0M 2019: $9.2M $9.2M 2019 2020: $7.6M $7.6M 2020 −18% 2021: -$78.8M -$78.8M 2021 2022: -$45.4M -$45.4M 2022 −42% 2023: -$59.2M -$59.2M 2023 +30% 2024: $34.8M $34.8M 2024 2025: $139.9M $139.9M 2025 +302% Capital spending7 3 $26.8M in 2025+13% since 2022 0 $20.0M $40.0M $60.0M 2022: $23.8M $23.8M 2022 2023: $36.0M $36.0M 2023 +51% 2024: $41.4M $41.4M 2024 +15% 2025: $26.8M $26.8M 2025 −35% Free cash flow7 3 $113.1M in 2025-$100.0M 0 $100.0M $200.0M 2022: -$69.2M -$69.2M 2022 2023: -$95.2M -$95.2M 2023 +38% 2024: -$6.6M -$6.6M 2024 −93% 2025: $113.1M $113.1M 2025 Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2019 2020 2021 2022 2023 2024 2025 Cash from operations $9.2M4 $7.6M5 -$78.8M6 -$45.4M7 -$59.2M3 $34.8M3 $139.9M3 Capital spending $23.8M7 $36.0M3 $41.4M3 $26.8M3 Free cash flow -$69.2M -$95.2M -$6.6M $113.1M
Compare Alignment Healthcare, Inc. with another company
Recent filings
Oct 8, 2026 8-K Oct 7, 2026 4 Oct 5, 2026 SCHEDULE 13G/A Oct 5, 2026 144 Sep 18, 2026 4 Sep 16, 2026 144 Sep 16, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 10, 2026 144 Sep 9, 2026 144 Sep 9, 2026 144 Aug 18, 2026 4 Aug 14, 2026 144 Aug 13, 2026 SCHEDULE 13G Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
